You have read all your free articles, to continue reading subscribe to read the rest of this content.
OxThera has appointed Matthew Gantz as their new CEO. He succeeds Elisabeth Lindner as CEO, who will continue as COO of Oxthera overseeing the Oxabact program. OxThera is developing a novel treatment, Oxabact, for Primary hyperoxaluria (PH), a fatal disease in children, and where there are Already a subscriber Login You have read…
The company announces that Nasdaq Stockholm decided to halt trading in the company's share as a result of share price movements. Immunicum cannot assess whether these movements are related to information leakage from an ongoing negotiation for a development collaboration. The company therefore wiAlready a subscriber Login You have read…
AstraZeneca will open a new manufacturing and packaging facility in Kaluga, Russia, dedicated to the local supply of innovative medicines. In 2011 AstraZeneca was one of the first multinational pharmaceutical companies to announce plans to invest in the construction of a dedicated manufacturing fAlready a subscriber Login You have read…
PILA PHARMA passes the start-up phase, prepares for efficacy trials and increases focus on 'Effective and Affordable Medicine' by electing the health economist Ulrikka Klarskov Kjær to the Board of Directors. The company, founded in 2014, now counts +10 core members and has thus passed the "starAlready a subscriber Login…
